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ABSTRACT 1 
The risk factors for the recurrence of head and neck cancer are classified as high or 2 
intermediate risk. Intermediate risks include multiple positive nodes without 3 
extracapsular nodal spread, perineural/vascular invasions, pT3/T4 primary tumors, and 4 
positive level IV/V nodes. However, little evidence is available to validate intermediate 5 
risk factors. We analyzed perineural/vascular invasions in 89 patients who underwent 6 
radical surgery for oral tongue squamous cell carcinoma, whose records were reviewed 7 
retrospectively. Perineural and vascular invasions were found in 27.0 and 23.6% of 8 
cases, respectively, and both had a strong relationship with histopathological nodal 9 
status (P = 0.005). The 5-year disease specific survival and overall survival rates of 10 
patients with perineural invasion were significantly lower than those of patients without 11 
perineural invasion (P < 0.001 and P = 0.002, respectively). The 5-year disease specific 12 
survival of UICC stage I and II cases with perineural/vascular invasion was 13 
significantly lower than those without (P < 0.001 and P = 0.008, respectively). 14 
Perineural/vascular invasions are risk factors for regional metastasis and poor prognosis. 15 
We recommend elective neck dissection when perineural/vascular invasions are found 16 
in clinical stage I and II cases. The accumulation of further evidence to consider 17 
intermediate risks is required. 18 
  19 
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INTRODUCTION 1 
Extracapsular nodal spread and the presence of positive margins are major adverse 2 
prognostic factors for survival in head and neck cancer. Patients with these prognostic 3 
factors are considered to be at high risk of recurrence and have a survival benefit of 4 
postoperative adjuvant chemoradiotherapy in head and neck squamous cell carcinoma1-3. 5 
Moreover, intermediate risk factors (multiple positive nodes without extracapsular 6 
nodal spread, perineural/vascular invasions, pT3 or pT4 primary tumors, and oral cavity 7 
or oropharyngeal primary cancers with positive level IV/V nodes) are established as 8 
indications that patients should undergo postoperative radiation therapy (RT) and that 9 
adjuvant chemoradiotherapy should be considered1-3. The postoperative management of 10 
high-risk disease has been clarified by two multicenter randomized trials: The Radiation 11 
Therapy Oncology Group (RTOG) trial #95012, and The European Organization for 12 
Research and Treatment of Cancer (EORTC) trial #229313. These two trials revealed 13 
common risk factors for the recurrence of oral cancer such as extracapsular nodal spread, 14 
positive surgical margins, and multiple positive nodes without extracapsular nodal 15 
spread4. However, the RTOG recently demonstrated that patients with two or more 16 
positive lymph nodes did not benefit from adding chemotherapy to RT5. Therefore, the 17 
criteria for high or intermediate risk factors that suggest postoperative adjuvant therapy 18 
are controversial and need to be studied further. In particular, not many studies have 19 
discussed the intermediate risk factors: only the RTOG trial #9501 and EORTC trial 20 
#229311-3. Nevertheless, several studies have reported adverse effects associated with 21 
chemoradiotherapy6,7. Therefore, it is necessary to accumulate evidence regarding the 22 
truly effective treatments for patients with oral cancer in order to perform the correct 23 
postoperative adjuvant treatments. Perineural and vascular invasions are defined as 24 
 4 
intermediate risk factors. Some reports revealed a relationship between 1 
perineural/vascular invasions and prognosis in oral tongue squamous cell carcinoma 2 
(OTSCC) patients8-22. However, the contribution of perineural and vascular invasions to 3 
prognosis remains unclear because of contradictory reports. 4 
In this study, we reconsidered the high and intermediate risk factors for the recurrence 5 
of oral cancer, and particularly analyzed the relationship between perineural/vascular 6 
invasions and prognosis. 7 
 8 
MATERIALS AND METHODS 9 
Patients and pathological examinations 10 
The records of 89 patients who underwent radical surgery for OTSCC, which was 11 
previously untreated, between January 2001 and December 2011 were reviewed 12 
retrospectively. The study cohort included patients with histologically confirmed 13 
OTSCC and a minimum follow-up of 12 months. All study patients underwent 14 
extensive pretreatment evaluations, including blood chemistry, complete blood cell 15 
count, chest X-ray, computed tomography (CT) and/or magnetic resonance imaging 16 
(MRI) of the head and neck area, ultrasonic echo (US), thoracoabdominal CT, and 17 
provided informed consent to participate in the study. In our institution, surgery alone 18 
was preferred for the initial treatment of patients with oral cancer. However, patients 19 
who hesitated to consent to surgical intervention or inoperable patients with 20 
unresectable cancer and/or severe systemic illness were selected for chemotherapy, 21 
radiation therapy and/or supportive palliation. All patients underwent glossectomy with 22 
curative intent. Neck dissection was performed for the cN positive cases and cN 23 
negative cases that need tongue reconstructive surgery because of the size of primary 24 
 5 
tumor. No sentinel lymph node biopsy was performed. Postoperative adjuvant 1 
chemo/radiotherapy or radiation therapy was undergone in accordance with current the 2 
National Comprehensive Cancer Network (NCCN) guidelines1. Patients who had 3 
adverse features (high risk feature; extracapsular nodal spread and the presence of 4 
positive margins, intermediate risk feature; multiple positive nodes without 5 
extracapsular nodal spread, perineural/vascular invasions, pT3/T4 primary tumors, and 6 
positive level IV/V nodes.) were treated depending on the degree of the risk. Clinical 7 
staging was defined by palpation, inspection, CT, MRI, US, and so on according to the 8 
International Union against Cancer (UICC) TNM classification system23. Tumors were 9 
classified histopathologically as well-, moderately-, or poorly-differentiated according 10 
to their cellular differentiation, as defined by the World Health Organization criteria23. 11 
The pattern of invasion (POI) was examined at the host/tumor interface; POI types 1–4 12 
were defined previously by Bryne et al.24. The depth of invasion (DOI) was measured as 13 
the infiltrative portion of the tumor that extended below the surface of the adjacent 14 
mucosa. Previous studies demonstrated that a DOI ≥4 mm had predictive value for 15 
cervical lymph node metastasis in patients with OTSCC25-27; therefore, DOI was 16 
classified as ≥4 and <4 mm in the current study. A previous large cohort study 17 
demonstrated that a pathological margin distance ≤4 mm was significantly associated 18 
with locoregional recurrence28; therefore, surgical margin status was classified as 19 
superficial (>4 mm) and deep (≤4 mm) in this study. Perineural invasion was defined as 20 
the presence of tumor cells within any of the three layers (the epineurium, perineurium, 21 
and endoneurium) of the nerve sheath. Vascular invasion was defined as the clear 22 
presence of tumor cells within a vascular space (lymphatic space or blood vessel), and 23 
the tumor was required to be adhered to the vessel endothelium or attached to a 24 
 6 
thrombus in the vessel. Expert pathologists who were unaware of the clinical outcomes 1 
performed all pathological assessments. Disease-specific survival (DSS) was calculated 2 
from the time of initial examination to the time of death related to local, regional, or 3 
distant recurrence/metastasis of the disease or the time of last follow-up. Overall 4 
survival (OS) was calculated from the time of initial examination to the time of death or 5 
last follow-up. 6 
Statistical analysis 7 
Statistical analyses were performed using StatMate IV (Atms Co., Tokyo, Japan). 8 
Categorical data were assessed using the chi-squared or Fisher's exact tests, as 9 
appropriate. The clinicopathological information of perineural/vascular invasions were 10 
compared using chi-squared or Fisher's exact tests, as appropriate. The 11 
clinicopathological information included pT stages, histopathological nodal status, 12 
UICC stages, POI, local recurrence, and treatment. DSS and OS were calculated using 13 
the Kaplan–Meier method, and significance was evaluated using the log-rank test. A 14 
value of P < 0.05 was considered to be significant. 15 
 16 
RESULTS 17 
Patient characteristics 18 
The patient demographics are summarized in Table 1. The male-to-female ratio was 19 
1.28, and 50 subjects were male. The mean age at diagnosis was 63.4 years (range, 28–20 
88 years). Perineural invasion was found in 24 of 89 (27.0%) patients, and vascular 21 
invasion was found in 21 (23.6%) individuals. Histopathological lymph node metastasis 22 
was found in 25 (28.1%) patients. Local recurrence developed in 11 patients (12.4%) 23 
during the follow-up period. Postoperative distant metastasis was occurred in 3 (3.3%) 24 
 7 
patients. The mean follow-up period of the whole series was 49.4 months (range, 3–125 1 
months). 2 
Association of perineural invasion with clinicopathological factors and survival 3 
Perineural invasion was associated significantly with T-classification, histopathological 4 
nodal status, POI, DOI, and distant metastasis, but not with local recurrence (Table 2). 5 
Univariate analysis using the two-tailed Fisher’s exact tests revealed that perineural 6 
invasion had a strong relationship with T-classification (P = 0.02), histopathological 7 
nodal status (P = 0.005), POI (P < 0.001), DOI (P < 0.001), and distantmetastasis (P = 8 
0.02). Kaplan–Meier analyses followed by log-rank tests showed that perineural 9 
invasion was significantly associated with 5-year DSS and OS (Figure 1A, B). The 10 
5-year DSS and OS of patients with perineural invasion were significantly lower than 11 
those of patients without perineural invasion (P < 0.001 and P = 0.002, respectively). 12 
The 5-year DSS of individuals with perineural invasion was 60.9%, compared with 13 
96.7% in those without. Similarly, the 5-year OS of patients with perineural invasion 14 
was 60.9%, compared with 90.2% in those without perineural invasion. 15 
Association of vascular invasion with clinicopathological factors and survival 16 
Vascular invasion was significantly associated with histopathological nodal status and 17 
DOI but not with local recurrence and distant metastasis (Table 2). Univariate analysis 18 
revealed that vascular invasion was a risk factor for histopathological nodal status (P = 19 
0.005) and had a strong relationship with DOI (P = 0.01). The Kaplan–Meier analysis 20 
followed by log-rank tests revealed that vascular invasion was significantly associated 21 
with 5-year DSS (Figure 1C). The 5-year DSS of patients with vascular invasion was 22 
significantly lower than that of those without vascular invasion (P = 0.03). However, 23 
there was no relationship between vascular invasion and 5-year OS (P = 0.12; Figure 24 
 8 
1D). The 5-year DSS of patients with vascular invasion was 70.9%, compared with 1 
89.4% in those without. Similarly, the 5-year OS of individuals with and without 2 
vascular invasion was 70.9% and 89.2%, respectively. 3 
Correlation between perineural and vascular invasion and UICC stage-specific survival 4 
rates 5 
We next analyzed the prognosis of patients with different UICC stage tumors. The 6 
5-year DSS of individuals with UICC stage I and II tumors with perineural invasion was 7 
significantly lower than those without perineural invasion (P < 0.001) (Figure 2A). In 8 
contrast, there was no difference in the 5-year DSS of UICC stage III and IV tumors 9 
with and without perineural invasion (Figure 2B). Similarly, the 5-year DSS of patients 10 
UICC stage I and II tumors with vascular invasion was significantly lower than those 11 
without vascular invasion (P = 0.008) (Figure 2C). In contrast, there was no difference 12 
in the 5-year DSS of vascular invasion-positive and -negative cases among those with 13 
UICC stage III and IV (Figure 2D). The 5-year DSS was 54.2% and 98.1% in stage I 14 
and II cancers that were positive and negative for perineural invasion, respectively. 15 
Similarly, the 5-year DSS was 64.7% in vascular invasion-positive cases compared with 16 
92.9% in -negative cases among patients with stage I and II cancers. These TNM 17 
classifications were clinically defined. Thirteen of 72 cTNM stage I and II cancers were 18 
upstaged to stage III and IV after pathological findings because of occult positive lymph 19 
nodes. Compared the upstaged cases with no changed cases, there was no significant 20 
difference for DSS. 21 
Correlation between perineural and vascular invasion and DOI-specific survival rates 22 
Perineural and vascular invasion had strong relation with DOI, respectively. Because 23 
perineural/vascular invasion were possible to just be a surrogate marker for DOI, we 24 
 9 
evaluated the relationship between perineural/vascular invasion and DSS in condition 1 
that each DOI groups (<4mm; n=55, ≥4mm; n=34) eliminating influence of DOI. In 2 
DOI <4mm group, only 2 patients were dead. It was difficult to dissert the tendency. 3 
Then, the relations were evaluated in DOI ≥4mm group. The results were shown in 4 
Table 3. Perineural invasion had significant relationship with DSS in DOI ≥4mm group 5 
(P = 0.04). On the other hand, vascular invasion had no relationship. 6 
 7 
DISCUSSION 8 
Perineural invasion is a well-known predictor of poor outcome in colorectal, pancreatic, 9 
and salivary gland cancers8,9. Although the perineural invasion of head and neck cancer 10 
was reported first by Liebig et al.10, there are no unified perineural invasion 11 
classifications in oral cancer. The frequency of perineural invasion in oral squamous 12 
cell carcinoma was reported to be 2–82%11,12. In addition, some studies revealed a 13 
correlation between perineural invasion and prognostic factors11-16. Some reports 14 
suggested that perineural invasion had no effect on 5-year local control and OS13,14. In 15 
contrast, other studies demonstrated that perineural invasion was significantly related to 16 
local recurrence, regional metastasis, and survival11,15. In the present study, perineural 17 
invasion was unrelated to local recurrence, but had a strong relationship with regional 18 
metastasis and survival. Chatzistefanou et al.16 also concluded that perineural invasion 19 
found to be an independent prognosticator for neck metastasis and regional recurrence. 20 
Consistent with this, some previous studies revealed that vascular invasion increased the 21 
risk of regional metastasis and poor prognosis12. In contrast, other reports demonstrated 22 
that vascular invasion was not related to any prognostic factors8-19. In the current study, 23 
vascular invasion-positive status was related to the occurrence of nodal metastasis and 24 
 10 
had a strong relationship with 5-year DSS, but did not affect local recurrence and OS. 1 
Distant metastasis had a relation with perineural invasion and no relation with vascular 2 
invasion in present study. However, It is difficult to discuss about this point because 3 
distant metastasis were occurred only 3 cases in the current study. These results suggest 4 
that perineural/vascular invasions are effective predictors of regional metastasis. In 5 
addition, perineural invasion may be a clinical predictor of survival. 6 
The current study also compared the relationship between perineural/vascular invasion 7 
and prognosis according to UICC stage. Perineural invasion-negative and vascular 8 
invasion-negative cases had a better prognosis than did perineural invasion-positive and 9 
vascular invasion-positive cases in UICC stage I and II patients. In contrast, there were 10 
no significant relationship between perineural/vascular invasions and prognosis in 11 
UICC stage III and IV patients. These results suggest that perineural and vascular 12 
invasion are important factors for predicting prognosis during the early stages of 13 
OTSCC. Thirteen cases of stage I and II cancers were upstaged to stage III and IV for a 14 
reason of occult lymph node metastasis. However, these upstaged 13 cases didn’t show 15 
worse prognosis. These results suggest that perineural invasion and vascular invasion 16 
are acceptable for prognosticator for clinically defined early stage OTSCC. 17 
Previous studies revealed that patients with high-risk factors (extracapsular nodal spread 18 
and/or positive surgical margin) require adjuvant chemoradiotherapy1-3. However, the 19 
amplifying effect of chemotherapy to RT is not elucidate for the cases of presence of 20 
intermediate risk factors (multiple positive nodes without extracapsular nodal spread, 21 
perineural/vascular invasions, pT3 or pT4 primary tumors, and oral cavity or 22 
oropharyngeal primary cancers with positive level IV or V nodes). The criteria for the 23 
use of adjuvant therapy in intermediate risk patients are unclear. Moreover, it remains 24 
 11 
unclear which intermediate risk factor has the strongest relationship with prognosis. In 1 
the current study, the relationship between the intermediate risk factors of perineural 2 
and vascular invasion and prognosis was evaluated. Although both were related to 3 
regional metastasis and DSS, only a perineural invasion-positive status decreased OS. 4 
These results suggest that various intermediate risk factors have different relationships 5 
with prognosis. 6 
Generally, risk factors are given scores or rankings29, and the diagnosis and treatment 7 
strategies of various diseases are decided according to these scores. Evaluating the 8 
priority of each intermediate risk is needed. Finally, criteria need to be defined to 9 
determine the optimal postoperative treatment of patients with OTSCC. Therefore it is 10 
important that more studies are performed that consider intermediate risks, similar to the 11 
present study. 12 
DOI is currently the best predictor of occult metastasis; therefore, it should be used as a 13 
guide for elective neck dissection. For tumors with a depth >4 mm, elective neck 14 
dissection should be considered if RT is not planned. For those with a depth <2 mm, 15 
elective neck dissection is only considered in highly selective situations. For those with 16 
a depth of 2–4 mm, clinical judgment (regarding the reliability of follow-up, clinical 17 
suspicions, and other factors) must be used to determine the suitability of elective 18 
dissection1,25-27. The present study demonstrated the strong relation between 19 
perineural/vascular invasion and DOI. There was capability that perineural/vascular 20 
invasion was just a surrogate marker for DOI. Evaluating the independent role of 21 
perineural/vascular invasion eliminating the influence of DOI, perineural invasion was 22 
suggested the strong prognosticator. The current study suggested that perineural and 23 
vascular invasions are related to neck metastasis and survival in patients with early 24 
 12 
stage OTSCC. It is possible that cases of OTSCC with perineural/vascular invasion may 1 
have already metastasized regionally. Some previous reports suggested that perineural 2 
invasion should be considered when making the decision whether to perform elective 3 
neck dissection and which postoperative treatment to use16,20-22. The results of the 4 
current study suggest that elective neck dissection should be considered if perineural or 5 
vascular invasion is observed. Until recent years, the effectiveness of sentinel lymph 6 
node biopsy had been obscure. Therefore, our institution had not performed sentinel 7 
lymph node biopsy. Actually in this study, we didn’t undergo sentinel lymph node 8 
biopsy. However, recent review concluded the high detection rate of sentinel lymph 9 
node and the high sensitivity of the test justify an important role of sentinel lymph node 10 
biopsy in the diagnostic pathway of cT1/T2 oral cavity squamous cell carcinoma 11 
patients31. Latest NCCN guidelines also added sentinel lymph node biopsy in treatment 12 
algorithm about T1-2N0 oral cavity cancer. We should consider performing sentinel 13 
lymph node biopsy in the future. It is important to decide the neck dissection 14 
comprehensively by perineural/vascular invasion, DOI, sentinel lymph node biopsy, and 15 
so on. 16 
On the other hand, the present study did not evaluate the effect of preventive 17 
chemoradiotherapy and RT (with irradiation extending to the neck region) because of 18 
our no experiences. The appropriate extension of the irradiating range for OTSCC cases 19 
with perineural/vascular invasion should be analyzed further. 20 
In conclusion, perineural and vascular invasion are risk factors for regional metastasis 21 
and adverse prognosis. In particular, perineural invasion has a strong relationship with 22 
prognosis. We recommend that elective neck dissection should be considered when 23 
 13 
perineural or vascular invasion is found in tumor samples obtained during preoperative 1 
incisional biopsy in clinical stage I and II cases. 2 
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CAPTIONS TO ILLUSTRATIONS 1 
Figure 1. Comparison of the Kaplan–Meier curves for 5-year disease-specific survival 2 
(DSS) and overall survival (OS) in cases with different perineural and vascular invasion 3 
statuses. A, DSS according to perineural invasion status; B, OS according to perineural 4 
invasion status; C, DSS according to vascular invasion status; D, OS according to 5 
vascular invasion status. 6 
 7 
Figure 2. Comparison of Kaplan–Meier curves for 5-year disease-specific survival 8 
(DSS) according to UICC stage-specific perineural and vascular invasion. A, DSS 9 
according to perineural invasion status in UICC stage I and II cases; B, DSS according 10 
to perineural invasion status in UICC stage II and IV cases; C, DSS according to 11 
vascular invasion status in UICC stage I and II cases; D, DSS according to perineural 12 
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Table 1. Demographic characteristics of 89 patients. 
Characteristics No. of cases (%) 
Gender 






   Age 






   Disease stage 
   I  
 
37 (41.6) 






 IV  
 
8 (9.0) 
   Histological grade 









   Pattern of invasion 












   Depth of invasion 






   Surgical margin 






   Perineural invasion 






   Vascular invasion






   Nodal status 




   Local recurrence 
  No 
 
78 (87.6) 
 Yes  11 (12.4) 
 Distant metastasis 
  No 
 
86 (96.7) 
 Yes  3 (3.3) 
Table 2.  Association of perineural/vascular invasions with clinicopathological factors. 
  PNI + PNI - P value 
 
VI + VI - P value 
Gender  
   
    Male  12 38 NS 
 
13 37 NS 








    ≥64  12 36 NS 
 
11 37 NS 




          pT stage 
    
    T1+T2 
 
19 63 0.02 
 
18 64 NS 
T3+T4 
 
5 2  
 
3 4 
          Histopathological nodal status 
   
    No metastasis 12 52 0.005 
 
10 54 0.005 
Metastasis 12 13  
 
11 14 
          UICC stage 
   
    I, II  
 
14 59 NS 
 
14 58 NS 
III, IV  
 
5 6  
 
7 10 
          Pattern of invasion 
   
    1+2+3 
 
12 59 ＜0.001 
 
14 57 NS 
4 
 
12 6  
 
7 11 
          Depth of invasion    
 <4mm 4 51 ＜0.001  8 47 0.01 
 ≥4mm 20 14   13 21  
        
Local recurrence 
   
    No 
 
19 59 NS 
 







        
Distant metastasis        
No  21 65 0.02  21 65 NS 
Yes  3 0   0 3  
         Disease specific survival 
   
    Alive 
 
17 62 0.004 
 
16 62 NS 
Dead 
 
7 3  
 
5 6 
          Overall survival 
   
    
Alive 
 
16 60 0.007 
 
16 59 NS 
Dead 
 
8 5  
 
5 9 
  PNI: perineural invasion VI: vascular invasion NS: Not significant 
 
Table 3.  Association of perineural/vascular invasions with DSS in DOI ≥4mm group. 
  PNI + PNI - P value  VI + VI - P value 
Disease specific survival        
Alive  12  13 0.04  10 15 NS 
Dead  8 1   3 6  
 PNI: perineural invasion VI: vascular invasion NS: Not significant 
 
